Invention Grant
- Patent Title: Nucleic acids encoding binding members to TNF alpha
-
Application No.: US16258886Application Date: 2019-01-28
-
Publication No.: US10995138B2Publication Date: 2021-05-04
- Inventor: Abdijapar Shamshiev , Titus Kretzschmar
- Applicant: Cell Medica Switzerland AG
- Applicant Address: CH Schlieren
- Assignee: Cell Medica Switzerland AG
- Current Assignee: Cell Medica Switzerland AG
- Current Assignee Address: CH Schlieren
- Agency: Myers Bigel, P.A.
- Priority: EP14001123 20140326
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C12N15/13 ; A61K39/395 ; A61K39/00
Abstract:
The present invention relates to anti-TNF alpha binding members and in particular to monovalent, high potency TNF alpha-binding antibody fragments being highly stable and soluble. Such binding members may be used in the treatment of inflammatory and other diseases as well as in diagnostics. Also provided are related nucleic acids, vectors, cells, and compositions.
Public/Granted literature
- US20190144532A1 BINDING MEMBERS TO TNF ALPHA Public/Granted day:2019-05-16
Information query
